This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Seth Gammon: Innovator in Monoclonal Antibody Research
Introduction
Seth Gammon is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work is essential for advancing therapeutic methods in various medical applications.
Latest Patents
Seth Gammon holds a patent for an innovative invention titled "Anti-B7-H3 Monoclonal Antibody and Methods of Use Thereof." This patent represents a crucial advancement in the treatment of diseases where B7-H3 plays a significant role. The patent showcases his dedication to improving healthcare through scientific innovation. He has 1 patent to his name.
Career Highlights
Seth is affiliated with The University of Texas System, where he engages in cutting-edge research. His position allows him to collaborate with other leading scientists and contribute to groundbreaking discoveries in the field of immunology. His work has the potential to impact patient care significantly.
Collaborations
Seth has worked alongside esteemed colleagues such as David Piwnica-Worms and Federica Pisaneschi. These collaborations enhance the research environment and foster innovation in their respective fields.
Conclusion
Seth Gammon is a dedicated inventor whose work in monoclonal antibody research is paving the way for new therapeutic approaches. His contributions to the scientific community are invaluable, and his patent reflects his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile